artificial intelligence (AI)

Distinguishes between benign and malignant liver lesions

The Indian GenAI market is expected to grow at a CAGR of 23.56% from 2024 to 2030

GlobalData projects a significant rise in AI utilisation in general surgery, driven by global population aging and increased…

The MoU outlines several key areas of collaboration, including anchoring tele-medicine hubs and enhancing the quality of…

Rahul Garg, Founder and CEO, DigioMed HealthTech highlights that for the Indian public health system, GenAI can bridge gaps in…

The report identifies a dozen case studies from Bangladesh, India, Morocco, Rwanda, South Africa and Vietnam, which are dedicated…

The qSpot-TB AI is a second-read computer aided detection & diagnosis device that analyses chest X-rays to localize all noted…

By leveraging the power of artificial intelligence, these institutions are enhancing diagnostic accuracy, improving operational…

The healthtech platform has collaborated with two healthcare players in India - RxDx and 2050 Healthcare and one innovation…

The funds will be utilised to enhance product development, refine Core-AI capabilities for health insights, and conduct…